Alzheimer’s disease (AD) is characterized by the accumulation of beta-amyloid (Aβ) and tau pathology ensuing neurodegeneration and cognitive decline [1, 2]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.